Tolnay Mate, Juang Yuang-Taung, Tsokos George C
Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Biochem J. 2002 Apr 1;363(Pt 1):127-36. doi: 10.1042/0264-6021:3630127.
Heterogeneous nuclear ribonucleoprotein D (hnRNP D) is implicated in transcriptional regulation. Alternative splicing of exons 2 and 7 generates four isoforms of the protein. We report here that only isoforms that contain the product of exon 2 (amino acids 79-97) were able to transactivate. Moreover, the exon 2-encoded protein domain alone was sufficient to drive transcription. TATA-binding protein and p300 interacted with a synthetic peptide corresponding to exon 2, and both proteins co-precipitated with hnRNP D. Stimulation of protein kinase A (PKA) and protein kinase C (PKC) synergistically induced the transactivating ability of hnRNP D, and the exon 2-encoded domain was sufficient for this inducibility. In kinase assays PKA phosphorylated Ser-87 of hnRNP D, whereas glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylated Ser-83, but only if Ser-87 had been pre-phosphorylated by PKA. Phosphorylation of Ser-87 enhanced, whereas phosphorylation of Ser-83 repressed, transactivation. Overexpression of GSK-3 beta inhibited transactivation by hnRNP D, but stimulation of PKC negated the inhibitory effect of GSK-3 beta. We suggest that a hierarchical phosphorylation pathway regulates the transactivating ability of hnRNP D: PKA activates hnRNP D, but at the same time renders it sensitive to inhibition by GSK-3 beta; the latter inhibition can be suspended by inactivating GSK-3 beta with PKC.
异质性细胞核核糖核蛋白D(hnRNP D)与转录调控有关。外显子2和7的可变剪接产生该蛋白的四种同工型。我们在此报告,只有包含外显子2产物(氨基酸79 - 97)的同工型能够反式激活。此外,仅外显子2编码的蛋白结构域就足以驱动转录。TATA结合蛋白和p300与对应于外显子2的合成肽相互作用,并且这两种蛋白都与hnRNP D共沉淀。蛋白激酶A(PKA)和蛋白激酶C(PKC)的刺激协同诱导hnRNP D的反式激活能力,并且外显子2编码的结构域对此诱导性是足够的。在激酶测定中,PKA使hnRNP D的Ser - 87磷酸化,而糖原合酶激酶 - 3β(GSK - 3β)使Ser - 83磷酸化,但前提是Ser - 87已被PKA预磷酸化。Ser - 87的磷酸化增强反式激活,而Ser - 83的磷酸化抑制反式激活。GSK - 3β的过表达抑制hnRNP D的反式激活,但PKC的刺激消除了GSK - 3β的抑制作用。我们认为一种分级磷酸化途径调节hnRNP D的反式激活能力:PKA激活hnRNP D,但同时使其对GSK - 3β的抑制敏感;通过用PKC使GSK - 3β失活可以消除后者的抑制作用。